News

ผงะ ! หนุ่มใหญ่ผูกคอลาโลก ทิ้งจดหมายลาพร้อมเงินทำศพ

- by Admin - 27 Comments.

ผงะ ! คนเก็บของเก่าแทบช็อก พบหนุ่มใหญ่ผูกคอห้อยโตงเตงในป่าข้างโรงเรียน ที่จ.นครนายก พบจดหมายลาสุดเศร้า พร้อมเงิน 3,000 บาท ระบุชัด ฝากกู้ภัยช่วยเผาร่าง 

นครนายก – วันนี้ ( 22 ก.พ.68) ตำรวจได้รับแจ้งมีคนพบศพชายผูกคอเสียชีวิตบริเวณป่าข้างโรงเรียนวัดทีวีพูลรังสรรค์ ต.ทรายมูล อ.องครักษ์ จ.นครนายก จึงไปตรวจสอบที่เกิดเหตุ พบรถ จยย. ทะเบียนปทุมธานี จอดอยู่ ใกล้กับผู้เสียชีวิต และพบร่างผู้เสียชีวิตอยู่ต้นไม้ภายในป่า ตรวจสอบเอกสารในตัว พบบัตรประชาชน ชื่อนายธนันดร อายุ 42 ปี ชาว จ.นนทบุรี และพบเอกสารภายในตัว จ่าหน้ากระดาษว่า “ให้คนที่นำร่างผมไปเผาหรือถ้าไม่พอ ขอติดไว้ชาติหน้าครับ” นอกจกานี้ภายในกระดาษ ยังพบเงินจำนวน 3,000 บาท และมีข้อความเขียนว่า “ถึงพี่กู้ภัยครับ ผมให้เงิน 3,000 บาทไว้ในกระดาษ ให้คนที่นำร่างของผมไปเผาให้หน่อย ไม่ต้องตามหาญาติ ผมไม่มีญาติและครอบครัว ไม่ต้องไปตามเขามารับ ให้เป็นศพไร้ญาติเผาได้เลย ผมปิดชีพตัวเอง ไม่ได้ถูกทำร้าย ผมก็แค่น้อยใจ และเครียดมาก ขอโทษที่เป็นภาระพวกพี่กู้ภัย รบกวนทำตามคำขอร้องสุดท้ายในชีวิตผมด้วย ขอบคุณครับ ฝากแค่โทรศัพท์กับรถมอเตอร์ไซร์ไปให้ลูกผมแค่นั้นครับหลังจากเผาผมแล้ว”

สอบถามนายกิมเล๊ง ผู้พบศพ เล่าให้ฟังว่าตนเดินเก็บของเก่ามาตามทางเรื่อย ๆ จนถึงบริเวณจุดดังกล่าว ตนรู้สึกเหนื่อย เลยแวะนั่งพัก ระหว่างนั่งพักอยู่ ก็หันไปเห็นเงาดำๆ จึงเดินเข้าไปดูใกล้ ๆ ก็พบว่าเป็นศพผูกคออยู่ เลยรีบออกมาจากจุดพบศพและรีบแจ้งเจ้าหน้าที่ทันที ซึ่งหลังจากนี้เจ้าหน้าที่จะส่งร่างไปชันสูตที่ รพ.มศว.องครักษ์ หาสาเหตุการเสียชีวิตที่แน่ชัด และจะได้พยายามติดต่อญาติผู้เสียชีวิตให้มารับศพไปประกอบพิธีทางศาสนาต่อไป แต่หากไม่พบญาติผู้เสียชีวิต ทางมูลนิธิกู้ภัยสว่างอริยะฯ จ.นครนายก ก็จะรับศพไว้ดำเนินการตามขี้นตอนต่อไป

Related Posts

สะพานกรุงเทพถล่ม เสียชีวิต 76 ราย!!

ประกาศแล้ว! กรมอุตุฯ เปิดรายชื่อจังหวัด 24 ชม. ข้างหน้า ฝนตกหนัก

แวบแรกนึกว่างู! คนไข้ถือถุงหิ้วใส่อะไรเขียวๆ มาหาหมอ พอเห็นชัดว่าคืออะไร หมอพยาบาลอึ้งทั้งแผนก

About Admin

View all posts by Admin →

27 Comments on “ผงะ ! หนุ่มใหญ่ผูกคอลาโลก ทิ้งจดหมายลาพร้อมเงินทำศพ”

  25. Sermorelin Ipamorelin Blend Peptide for Men is a combination therapy that targets the
    body’s natural growth hormone axis to promote anabolic effects, improve recovery, and support overall vitality.
    The blend brings together two distinct peptides: Sermorelin,
    a synthetic growth hormone releasing hormone (GHRH) analogue,
    and Ipamorelin, a selective growth hormone secretagogue.
    Together they create a synergistic effect that stimulates
    the pituitary gland to release endogenous growth hormone in a
    pulsatile manner, mimicking physiological patterns rather than producing constant high
    levels of the hormone.

    How Does Sermorelin Work?

    Sermorelin functions by binding to GHRH receptors located on somatotroph cells within the anterior pituitary.
    This interaction initiates a cascade that increases cyclic
    AMP production and promotes secretion of growth hormone into the bloodstream.

    Because Sermorelin is a short‑acting peptide, its influence peaks
    quickly and then diminishes, allowing natural feedback mechanisms to
    regulate hormone release. Ipamorelin complements
    this action by binding specifically to the ghrelin receptor (GHS-R1a) on pituitary cells.
    Unlike other secretagogues such as GHRP-2 or GHRP-6, ipamorelin benefits side effects’s
    selectivity results in a more focused growth hormone surge with minimal stimulation of prolactin and cortisol pathways.
    The dual activation ensures a robust yet balanced release that can be tailored through dosing schedules to achieve
    desired anabolic outcomes.

    Enhanced Muscle Growth and Strength

    The combined action of Sermorelin and Ipamorelin creates an environment conducive to muscle
    hypertrophy and strength gains. Elevated growth hormone levels boost
    insulin-like growth factor‑1 (IGF‑1) production in the
    liver and peripheral tissues, a key driver of protein synthesis within skeletal muscle fibers.
    IGF‑1 also promotes satellite cell proliferation and differentiation, facilitating repair of
    microtrauma incurred during resistance training. Additionally, higher circulating insulin levels induced by the peptide blend enhance amino acid uptake into muscle cells, further supporting anabolism.

    Beyond direct anabolic pathways, growth hormone improves lipid
    metabolism by increasing lipolysis in adipose tissue.

    The resulting reduction in fat mass can sharpen body composition and improve functional strength by lowering inert load
    during movement. Furthermore, growth hormone exerts anti‑catabolic
    effects on skeletal muscle by inhibiting proteolytic enzymes
    such as caspases and reducing oxidative stress markers.
    These mechanisms together translate into measurable increases in maximal voluntary contraction, endurance capacity,
    and recovery speed for athletes and bodybuilders alike.

    Side Effects of Sermorelin Ipamorelin Blend

    Like any peptide therapy that modulates endocrine function, the Sermorelin Ipamorelin blend carries potential side effects that users should consider.
    Common adverse reactions include:

    Injection site discomfort such as pain, swelling, or redness

    Transient water retention leading to mild edema around extremities

    Headaches and dizziness during initial dosing phases

    Temporary changes in appetite, often an increase due
    to ghrelin pathway activation

    Hormonal feedback effects that may alter sleep patterns, causing vivid dreams
    or insomnia

    Because the blend primarily stimulates growth hormone release without
    directly affecting prolactin or cortisol, severe endocrine disturbances are less frequent than with
    other secretagogues. However, chronic high levels of growth hormone can lead to insulin resistance,
    which in turn raises blood glucose and lipid abnormalities over
    time.

    Rare but more serious complications may involve:

    Development of arthralgia or joint pain as cartilage turnover shifts

    Increased intracranial pressure in susceptible individuals, presenting
    with visual disturbances

    Potential for neoplastic proliferation if used long term without
    medical supervision

    It is essential that users monitor blood work regularly,
    including fasting glucose, insulin levels, and lipid
    panels. Adjustments to dosage should be guided
    by a qualified healthcare professional to mitigate risks while
    maintaining therapeutic benefit.

    Conclusion

    The Sermorelin Ipamorelin blend offers a sophisticated approach to growth hormone
    optimization for men seeking enhanced muscle growth, strength, and recovery.
    By leveraging the distinct but complementary mechanisms of GHRH analogue and
    ghrelin receptor agonist, the therapy promotes natural hormone
    pulsatility with fewer systemic side effects than older peptide protocols.
    Nonetheless, awareness of potential adverse reactions—ranging from mild injection site irritation to more significant
    metabolic changes—is crucial for safe application. With proper dosing, monitoring,
    and professional oversight, users can harness the blend’s benefits while minimizing
    risks.

  27. BPC‑157 is a synthetic peptide that has attracted significant interest among athletes, researchers and individuals seeking natural approaches to healing
    and overall wellness. Often referred to as “Body Protective Compound 157,” it is derived from a protein found in the stomach lining and has shown remarkable potential across a range of medical conditions
    in preclinical studies.

    An In‑Depth Look at BPC‑157 Pure and Its Health Benefits

    BPC‑157 is available in a pure, crystalline form that can be
    dissolved in sterile water or saline for injection. When administered subcutaneously or intramuscularly, the
    peptide travels through the bloodstream to reach tissues that need repair.
    Researchers have documented its ability to accelerate tendon and ligament
    healing, reduce inflammation, improve blood vessel growth, and protect organs such as the liver
    and heart from damage.

    One of the most celebrated benefits is its effect
    on connective tissue repair. In animal models, BPC‑157 has been shown to shorten recovery times for injured tendons by
    up to 70 percent compared with untreated controls.
    The peptide also promotes collagen production while balancing the inflammatory response, which means scars are less pronounced and functionally stronger.

    Beyond musculoskeletal healing, BPC‑157 has anti‑inflammatory properties that extend to
    the gastrointestinal tract. It can reduce ulceration in the stomach and small intestine, protect against
    alcohol‑induced liver injury, and even improve symptoms of inflammatory bowel disease.
    In studies with mice suffering from colitis,
    treatment led to significant reductions in tissue damage
    and improved mucosal regeneration.

    The peptide also appears to have a protective effect
    on the nervous system. In rodent models of spinal cord injury,
    BPC‑157 accelerated functional recovery by promoting nerve growth factor expression and enhancing blood flow to damaged
    areas. Preliminary human reports suggest it may help with neuropathic pain and muscle cramps,
    though controlled trials are still pending.

    What Is BPC‑157?

    BPC‑157 is a 15‑amino acid peptide fragment that mimics the structure of a naturally occurring protein in the stomach.
    The full protein, known as Body Protective Compound or Gastric Pentadecapeptide, plays a role in maintaining mucosal integrity and modulating inflammatory pathways.
    By isolating this specific segment, scientists created a stable compound that can be synthesized
    in laboratories.

    The peptide’s sequence—pGlu-His-Pro-Gly-Arg-Phe-Pro-Asp-Val-Leu-Lys-Ser-Ala-Asn-Cys—is designed
    to resist rapid degradation by proteases, allowing it to remain active for longer periods once injected.
    BPC‑157 does not cross the blood–brain barrier directly,
    but its systemic effects on vascular health
    and cytokine modulation create an environment conducive to
    neural repair.

    Dosage protocols in research typically involve daily injections ranging from 200 to 500 micrograms per kilogram of
    body weight. The duration of treatment varies depending on the injury or condition being addressed, with many studies employing a
    two‑to‑four‑week course before evaluating outcomes. Importantly, BPC‑157 has been well tolerated in animal trials, with no significant adverse
    effects reported at therapeutic doses.

    Medically Reviewed By: Dr. Matthew Poteet, Pharm.D.

    Dr. Matthew Poteet is a licensed pharmacist who specializes in compounding and the clinical use of peptides.
    In his review of BPC‑157, he emphasizes the peptide’s strong preclinical evidence base while cautioning that human data are limited.

    According to Dr. Poteet, the most reliable information comes
    from controlled animal studies, which consistently demonstrate reduced
    healing times and lower inflammation markers.

    He advises practitioners to consider the legal status
    of peptides in their jurisdiction and to verify product purity through third‑party testing.
    Dr. Poteet also highlights that while BPC‑157 shows promise for tendon repair
    and gastrointestinal protection, patients should remain realistic about its current evidence level and use it as an adjunct rather than a replacement for conventional therapy.

    In summary, BPC‑157 is a promising peptide with a wide array of potential health benefits, from rapid
    tissue repair to anti‑inflammatory effects across multiple organ systems.
    Its pure form allows precise dosing and reliable delivery,
    making it an attractive option for individuals looking to support their body’s natural healing processes.
    However, until larger human trials are completed, users should approach BPC‑157
    with informed caution and under professional guidance.

Leave a Reply

Your email address will not be published. Required fields are marked *